Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia

Fig. 4

Time course of hemodynamic and immunohistochemistry of PAH models. a, b Significant differences were observed between each group, except between the PAH-2w and PAH-3w groups for RVSP (a) and Fulton index (b). c and d % MT (c) and VOS (d) increased over time within 5 weeks of PAH development; *p < 0.05, **p < 0.01, and ***p < 0.001. Treatment groups consisted of eight rats each in the control, PAH-1w, and PAH-2w groups, four rats in the PAH-3w group, and five rats in the PAH-5w group

Back to article page